At a glance
- Originator Suntory
- Class Anti-ischaemics; Nootropics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cerebral ischaemia; Neurological disorders
Most Recent Events
- 03 Mar 1997 Discontinued-Preclinical for Neurological disorders in Japan (Unknown route)
- 10 Dec 1996 Discontinued-Preclinical for Cerebral ischaemia in Japan (Unknown route)